Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aurinia Pharmaceuticals

8.21
+0.01000.12%
Post-market: 8.210.00000.00%16:41 EDT
Volume:751.10K
Turnover:6.19M
Market Cap:1.12B
PE:205.25
High:8.38
Open:8.21
Low:8.20
Close:8.20
Loading ...
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 17, 2021

Major Issues Report

8-K/A [Amend] - Current report
Aug 17, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 19, 2021

Major Issues Report

8-K - Current report
Jun 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 25, 2021

Major Issues Report

8-K - Current report
Jun 17, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Apr 30, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 27, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 24, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans